Want to see GB:ICON full AI Analyst Report?
Top Page
Iconic Labs plc
(LSE:ICON)
Select Model
Select Model
Rating:46Neutral
Price Target:
1.50 p
▲(0.00% Upside)
Action:Upgraded
Date:07/02/26
The score is held down primarily by very weak financial performance (near-zero revenue, negative operating earnings/cash flow, and negative equity with high debt), indicating significant business and balance-sheet risk. Technical indicators provide only modest near-term support (price above shorter moving averages with neutral momentum), while valuation is difficult to rely on due to the negative P/E and lack of dividend yield data.
Positive Factors
Public listing / access to capital markets
Being listed on the London Stock Exchange provides durable access to public capital, visibility with investors, and a formal governance framework. That structural advantage improves options for equity raises, rights issues or strategic investors to address the company’s funding needs over months.
Negative Factors
Revenue collapse / near-zero sales
Sustained near-zero revenue removes scale economics, destroys recurring cash inflows, and makes core business viability uncertain. Over months this limits ability to rebuild margins, retain clients, or generate predictable cash, raising existential risk absent new revenue sources.
Read all positive and negative factors
Positive Factors
Negative Factors
Public listing / access to capital markets
Being listed on the London Stock Exchange provides durable access to public capital, visibility with investors, and a formal governance framework. That structural advantage improves options for equity raises, rights issues or strategic investors to address the company’s funding needs over months.
Read all positive factors
Iconic Labs plc (ICON) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£285.27K
Dividend YieldN/A
Average Volume (3M)164.90K
Price to Earnings (P/E)―
Beta (1Y)-0.02
Revenue GrowthN/A
EPS Growth40.08%
CountryUK
Employees3
SectorCommunication Services
Sector Strength97
IndustryAdvertising Agencies
Share Statistics
EPS (TTM)-0.04
Shares Outstanding16,780,647
10 Day Avg. Volume257,741
30 Day Avg. Volume164,896
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.00
P/FCF Ratio-0.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Iconic Labs plc Business Overview & Revenue Model
Company Description
Iconic Labs Plc functions as a media and technology enterprise, primarily concentrating on digital marketing solutions and developing products powered by content and advanced technology. The company also engages in digital and social media publish...
How the Company Makes Money
null...
Iconic Labs plc Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2023 | Jun 2022 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 26.82K | 509.17K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 26.24K | 509.10K |
| EBITDA | -589.91K | -555.12K | -246.05K | 4.77M | -759.60K | -3.10M |
| Net Income | -604.38K | -628.23K | 418.95K | 4.77M | -762.00K | -7.70M |
Balance Sheet | ||||||
| Total Assets | 13.38K | 95.04K | 139.34K | 50.24K | 6.00 | 154.06K |
| Cash, Cash Equivalents and Short-Term Investments | 8.98K | 35.74K | 129.31K | 50.24K | 5.00 | 50.93K |
| Total Debt | 3.28M | 3.08M | 2.65M | 1.94M | 2.42M | 2.42M |
| Total Liabilities | 4.25M | 4.06M | 2.86M | 3.69M | 8.94M | 8.33M |
| Stockholders Equity | -4.23M | -3.96M | -2.72M | -3.64M | -8.94M | -8.18M |
Cash Flow | ||||||
| Free Cash Flow | -344.31K | -448.07K | -802.71K | -919.76K | -50.92K | 1.15M |
| Operating Cash Flow | -344.31K | -448.07K | -802.71K | -919.76K | -50.92K | 1.15M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 304.00K | 354.50K | 881.78K | 970.00K | 0.00 | -1.28M |
Iconic Labs plc Technical Analysis
Positive
1.50
Price Trends
1.56
Positive
1.55
Positive
1.88
Negative
Market Momentum
<0.01
Negative
64.51
Neutral
38.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ICON, the sentiment is Positive. The current price of 1.5 is above the 20-day moving average (MA) of 1.47, below the 50-day MA of 1.56, and below the 200-day MA of 1.88, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.51 is Neutral, neither overbought nor oversold. The STOCH value of 38.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ICON.
Iconic Labs plc Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | £1.59M | 1.94 | 68.09% | ― | 29.26% | ― | |
55 Neutral | £42.64M | 32.46 | 9.14% | 1.79% | -1.27% | -70.61% | |
54 Neutral | £19.48M | -1.02 | -28.86% | 0.22% | 1.84% | -1966.67% | |
49 Neutral | £7.81M | -7.01 | -15.78% | ― | -2.27% | -365.00% | |
46 Neutral | £285.27K | -0.39 | 14.75% | ― | ― | 40.08% | |
40 Neutral | £409.74K | >-0.01 | -148.46% | ― | ― | ― |
* Communication Services Sector Average
GB:ICON
Iconic Labs plc
1.70
-1.05
-38.18%
GB:MDZ
Mediazest
0.08
>-0.01
-3.75%
GB:TMG
The Mission Group
21.50
-1.00
-4.44%
GB:SYS1
System1
336.00
-86.07
-20.39%
GB:MIRI
Mirriad Advertising
0.01
0.00
0.00%
GB:DNM
Dianomi Plc
26.00
0.50
1.96%
Iconic Labs plc Corporate Events
Regulatory Filings and Compliance
Iconic Labs Confirms Total Voting Rights at 16.4 Million Shares
Neutral
Jul 31, 2026
Iconic Labs PLC has confirmed that, as of 31 July 2026, its issued share capital comprises 16,410,277 Ordinary Shares of £0.0001, each carrying one voting right. The company holds no shares in treasury, so the total number of voting rights fu...
Private Placements and FinancingRegulatory Filings and Compliance
Iconic Labs Boosts Share Capital After Convertible Note Conversion
Neutral
Jul 29, 2026
Iconic Labs PLC, a London-listed company whose ordinary shares represent its voting rights base, operates within the framework of U.K. financial regulation, including the FCA’s transparency regime and the Market Abuse Regulation. Its capital...
Business Operations and StrategyExecutive/Board Changes
Iconic Labs refreshes board with appointment of finance-focused director
Positive
Jul 1, 2026
Iconic Labs has reshaped its board, announcing the immediate departure of long-serving director Victor Humberdot and expressing appreciation for his contributions over the past two years. The move signals ongoing governance evolution as the compan...
Regulatory Filings and Compliance
Iconic Labs Confirms Total Voting Rights at 16 Million Shares
Neutral
Jun 30, 2026
Iconic Labs PLC has confirmed that, as of 30 June 2026, its issued share capital comprises 16,039,907 ordinary shares of £0.0001, each carrying one voting right, and that it holds no shares in treasury.The company has clarified that this tota...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Iconic Labs Converts Note and Expands Share Capital
Neutral
Jun 29, 2026
Iconic Labs PLC has converted one of its outstanding convertible notes into equity, issuing 370,370 new ordinary shares at a price of £0.0135 per share for a principal amount of £5,000. The new shares, which will rank pari passu with exi...
Private Placements and FinancingRegulatory Filings and Compliance
Iconic Labs Issues New Shares Following Convertible Note Conversion
Neutral
Jun 2, 2026
Iconic Labs PLC has received a valid notice to convert one of its convertible notes, resulting in the issuance of 458,716 new ordinary shares at a conversion price of £0.0109 for an aggregate principal amount of £5,000. The new shares, w...
Regulatory Filings and Compliance
Iconic Labs Sets Official Total Voting Rights at 15.58 Million Shares
Neutral
May 29, 2026
Iconic Labs PLC has confirmed that, as of 29 May 2026, its issued share capital comprises 15,581,191 ordinary shares of £0.0001 each, with every share carrying one voting right and no shares held in treasury. This disclosure sets the official...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.